Scott T. Reents

Companies

• AbbVieChief financial officer Jul 8, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AbbVie ABBV38,777 shares²$11.1M at $285.03Feb 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 27, 2026Shares withheld for tax 21,638 shares at $232.08 of AbbVie²
• Feb 18, 2026Granted 7,260 shares of AbbVie³
• Feb 18, 2026Granted 7,606 shares of AbbVie³
• Feb 18, 2026Granted 8,910 shares of AbbVie³
• Feb 18, 2026Granted 25,062 shares of AbbVie³
• Mar 14, 2025Sold 17,644 shares at $212.34 of AbbVie⁴
• Feb 28, 2025Shares withheld for tax 10,973 shares at $205.02 of AbbVie⁵
• Feb 13, 2025Granted 7,608 shares of AbbVie⁶
• Feb 13, 2025Granted 8,912 shares of AbbVie⁶
• Feb 13, 2025Granted 2,398 shares of AbbVie⁶
• Feb 13, 2025Granted 5,845 shares of AbbVie⁶
• Feb 28, 2024Shares withheld for tax 11,634 shares at $178.99 of AbbVie⁷
• Feb 23, 2024Sold 14,140 shares at $177.44 of AbbVie⁷
• Feb 23, 2024Exercised options 14,140 shares at $61.36 of AbbVie⁷
• Feb 15, 2024Granted 8,912 shares of AbbVie⁸
• Feb 15, 2024Granted 2,398 shares of AbbVie⁸
• Feb 15, 2024Granted 3,146 shares of AbbVie⁸
• Feb 15, 2024Granted 11,800 shares of AbbVie⁸
• Mar 1, 2023Sold 850 shares at $153.38 of AbbVie⁹
• Mar 1, 2023Sold 15,092 shares at $153.06 of AbbVie⁹
• Feb 28, 2023Shares withheld for tax 12,683 shares at $154.28 of AbbVie⁹
• Feb 16, 2023Granted 2,398 shares of AbbVie¹⁰
• Feb 16, 2023Granted 3,146 shares of AbbVie¹⁰
• Feb 16, 2023Granted 4,366 shares of AbbVie¹⁰
• Feb 16, 2023Granted 18,715 shares of AbbVie¹⁰